TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0110
0.00 (0.00%)
Sep 29, 2026, 4:11 PM AEST
TrivarX Revenue
In the fiscal year ending June 30, 2026, TrivarX had annual revenue of 14.57K AUD, down -98.59%. TrivarX had revenue of 12.30K in the half year ending June 30, 2026, a decrease of -98.58%.
Revenue
14.57K
Revenue Growth
-98.59%
P/S Ratio
871.25
Revenue / Employee
2.43K
Employees
6
Market Cap
12.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 14.57K | -1.02M | -98.59% |
| Jun 30, 2025 | 1.03M | 142.24K | 16.00% |
| Jun 30, 2024 | 888.83K | -71.62K | -7.46% |
| Jun 30, 2023 | 960.45K | -45.00K | -4.48% |
| Jun 30, 2022 | 1.01M | -258.10K | -20.43% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Adheris Health | 33.96M |
| Beamtree Holdings | 29.19M |
| Resonance Health | 15.75M |
| Global Health | 8.02M |
| Careteq | 6.08M |
| Vitasora Health | 4.84M |
| PainChek | 3.74M |
| Intelicare Holdings | 2.04M |